文献速递泌尿生殖与妇科肿瘤放疗姑息放疗与转移瘤

局部晚期宫颈癌根治性放化疗及图像引导自适应近距离放疗后的疲乏、失眠与潮热:EMBRACE研究分析

Fatigue, insomnia and hot flashes after definitive radiochemotherapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: An analysis from the EMBRACE study.
PubMed 文献 · Radiother Oncol · 2018-04-05

基于前瞻性、观察性、多中心EMBRACE研究,评估局部晚期宫颈癌患者根治性放化疗及图像引导自适应近距离放疗后疲乏、失眠与潮热的表现模式。共分析1176例患者,中位随访27个月,疲乏与失眠在治疗前即已存在且随访期间波动或恢复较小,潮热在治疗后明显增加,年轻年龄与三者风险升高显著相关。

要点

  • 疲乏与失眠以轻中度为主,且治疗前即已存在。
  • 潮热在治疗后明显增加,3年CTCAE G1/G2患病率为19%/5.9%。
  • 年轻年龄与疲乏、失眠和潮热风险显著升高相关。

核心结论

  • 疲乏、失眠与潮热主要发生在轻至中度范围;疲乏和失眠治疗前已存在、随访期间波动或恢复较小,潮热治疗后明显增加;需更多研究评估相关危险因素以制定干预策略。

研究设计与样本

  • 前瞻性、观察性、多中心EMBRACE研究,按CTCAE v.3及EORTC QLQ-C30/CX24在基线和定期随访中评估,共分析1176例患者,中位随访27个月。

主要发现

  • 基线CTCAE G1/G2疲乏患病率为29%/6.2%,失眠为18%/3.1%,潮热为7.9%/1.6%。
  • 3年CTCAE G1/G2患病率疲乏为29%/6.8%,失眠为17%/4.4%,潮热为19%/5.9%。
  • 3年CTCAE G≥3的累积估计疲乏为5.5%、失眠为4.7%、潮热为1.9%。
  • 患者报告的EORTC结局表现出相似的模式。
  • 年轻年龄与疲乏、失眠和潮热风险显著升高相关。

关键数值与推荐

  • CTCAE v.3分级中基线及3年G1/G2患病率、3年G≥3累积估计值见上述数值,患者报告结局采用EORTC QLQ-C30/CX24评估。

临床怎么用

  • 放疗科智能体可据此对局部晚期宫颈癌根治性放化疗及图像引导自适应近距离放疗患者进行疲乏、失眠与潮热的基线及随访症状监测,关注年轻患者,并识别需进一步评估干预的人群。

局限性

  • 原文指出需更多研究评估相关危险因素以制定干预策略;未报告其他具体局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the pattern of manifestation of fatigue, insomnia and hot flashes within the prospective, observational, multi-center EMBRACE study. METHODS: Morbidity was prospectively assessed according to CTCAE v.3 and patient-reported outcome with EORTC QLQ-C30/CX24 at baseline and regular follow-up. Analyses of crude incidence, prevalence rates and actuarial estimates were performed. RESULTS: A total of 1176 patients were analyzed with a median follow-up of 27 months. At baseline, CTCAE G1/G2 prevalence rates for fatigue were 29%/6.2%, for insomnia 18%/3.1% and for hot flashes 7.9%/1.6% with respective 3-year prevalence rates of 29%/6.8%, 17%/4.4% and 19%/5.9%. Similar patterns of manifestation were seen in patient-reported EORTC outcomes. The 3-year actuarial estimates for G ≥ 3 CTCAE fatigue, insomnia and hot flashes were 5.5%, 4.7% and 1.9%. Younger age was associated with significantly higher risk for fatigue, insomnia and hot flashes. CONCLUSION: Fatigue, insomnia and hot flashes occurred mainly in the mild to moderate range. Fatigue and insomnia were already present before treatment and showed minor fluctuations or recovery during follow-up, whereas hot flashes showed a considerable increase after treatment. More research is needed to evaluate contributing risk factors in order to define intervention strategies.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Smet S, Pötter R, Haie-Meder C, et al. Fatigue, insomnia and hot flashes after definitive radiochemotherapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: An analysis from the EMBRACE study. Radiother Oncol. 2018. PMID: 29627137. doi:10.1016/j.radonc.2018.03.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。